Wellgistics Health, Inc. (WGRX): debt financing — Wellgistics Health to acquire Peek Healthcare for $2M cash, $6M note, and shares

Wellgistics Health, Inc.

Merger: Peek acquired for $2M cash (adjusted) + $6M note (4.5% for 3 years) + 1,777,778 shares; 1,270,163 earn-out subject to $8.8M revenue target by Dec 2027.
Peek's digital prescription platform serves >2,500 patients with $1.5M annual revenue; expected to be immediately accretive.
Related party note: $500k from Sansur Assoc. (Chairman's entity), 10% unsecured, due Oct 2025.
ELOC with Hudson Global Ventures for up to $50M over ~24 months at up to 10% discount; commitment fee 152k shares.
Director Sajid Sayed resigns (no disagreement); Michael Peterson appointed independent director and audit committee chair.

item 1.01 item 2.03 item 3.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sajid Sayed

Director

WGRX · Wellgistics Health, Inc.

Effective: 2025-04-09
Successor: Michael L. Peterson
Filed: April 11, 2025, 7:59 PM ET

Sajid Sayed informed the Company’s board of directors of his intent to resign as a director of the Company, effective immediately.

Appointed

Michael L. Peterson

Director

WGRX · Wellgistics Health, Inc.

Effective: 2025-04-10
Filed: April 11, 2025, 7:59 PM ET

the Board appointed Michael L. Peterson to fill the vacancy created as a result of Mr. Sayed’s departure.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Wellgistics Health, Inc. incurred loan of principal amount of $6,000,000 at rate of 4.5%, compounding annually maturing third anniversary of the date such note is made.

Instrument: loan
Principal: principal amount of $6,000,000
Rate: rate of 4.5%, compounding annually
Maturity: third anniversary of the date such note is made
Event: incurrence

Exact text from the filing

an unsecured promissory note made by the Company (the “Note”) in the principal amount of $6,000,000 bearing interest at the rate of 4.5%, compounding annually, and maturing on the third anniversary of the date such note is made.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Sajid Sayed resigned as Director at Wellgistics Health, Inc..

Action: resigned
Role: Director

Exact text from the filing

Sajid Sayed informed the Company’s board of directors of his intent to resign as a director of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael L. Peterson was appointed as Director at Wellgistics Health, Inc..

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Michael L. Peterson to fill the vacancy created as a result of Mr. Sayed’s departure.

View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-003835

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.